Evidence map›Paper›PMID 11593403›Full record

ArticleOncogene2001

Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.

M Ljungman, H M O'Hagan, M T Paulsen

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. RPA and ATR link transcriptional stress to p53.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M LjungmanDepartment of Radiation Oncology, Division of Cancer Biology, University of Michigan Comprehensive Cancer Center, 150 E. Medical Center Drive, Ann Arbor, MI 48109-0936, USA. ljungman@umich.edu
H M O'Hagan
M T Paulsen
University of Michigan–Ann Arbor · USMichigan Cancer Research Consortium · US

Funding

REGULATION OF P53 STABILITY BY SER315 PHOSPHORYLATIONR01CA082376 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LJUNGMAN, MATS · 1999 to 2002
$627k
NCI NIH HHS CA 82376-01
6 · The paper itself

Abstract

Blockage of transcription has been shown to induce the tumor suppressor p53 in human cells. We here show that RNA synthesis inhibitors blocking the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II, such as DRB and H7, induced rapid nuclear accumulation of p53 proteins that were not phosphorylated at ser15 or acetylated at lys382. In contrast, agents that inhibit the elongation phase of transcription, such as UV light, camptothecin or actinomycin D, induced the accumulation of nuclear p53 proteins that were modified at both of these sites. Furthermore, using a panel of DNA repair-deficient cells we show that persistent DNA lesions in the transcribed strand of active genes are responsible for the induction of the ser15 and lys382 modifications following UV-irradiation. We conclude that inhibition of transcription is sufficient for the accumulation of p53 in the nucleus regardless of whether the ser15 site of p53 is phosphorylated or not. Importantly, blockage of the elongation phase of transcription triggers a distinct signaling pathway leading to p53 modifications on ser15 and lys382. We propose that the elongating RNA polymerase complex may act as a sensor of DNA damage and as an integrator of cellular stress signals.

Indexed as

Transcription, GeneticAcetylationCell NucleusCells, CulturedCockayne SyndromeDNA DamageGene Expression RegulationHumansLysineNucleic Acid Synthesis InhibitorsPhosphorylationPromoter Regions, GeneticRNA Polymerase IISerineTumor Cells, CulturedTumor Suppressor Protein p53LysineNucleic Acid Synthesis InhibitorsRNA Polymerase IISerineTumor Suppressor Protein p53

Identifiers

PMID11593403
OpenAlexW2109017018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.